Arsenic carcinogenesis and disruption of histone variant H3.3 assembly
Arsenic carcinogenesis and disruption of histone variant H3.3 assembly
批准号:
10631227
负责人:
Max Costa
金额:
$52.99万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-06 至 2024-05-31
关键词:
Amino AcidsArsenicAttenuatedBindingBinding ProteinsCarcinogensCell Cycle ArrestCell Cycle ProgressionCellsChIP-seqChromatin ModelingChromatin StructureChromosome SegregationCoupledDNA RepairDefectDevelopmentEctopic ExpressionEnhancersEnvironmentEpigenetic ProcessExposure toGene ExpressionGenesGenetic TranscriptionGenome StabilityGenomic InstabilityHeterochromatinHistone H3Histone H3.3HistonesLinkLungMalignant NeoplasmsMalignant neoplasm of liverMalignant neoplasm of lungMalignant neoplasm of urinary bladderMapsMass Spectrum AnalysisMediatingMessenger RNAMetalsMolecular ChaperonesMusNucleosomesNude MicePersonsPlayPoly APoly(A) TailPolyadenylationPost-Translational Protein ProcessingProcessPropertyProteinsRNARegulator GenesRegulatory ElementRenal carcinomaRoleSiteSkin CancerStructureTestingTherapeutic InterventionTissuesVariantarsenic carcinogenesisarsenic-induced carcinogenesiscancer typecarcinogenesiscarcinogenicitycell growthcell transformationexposed human populationgenome-widehistone modificationhuman diseasein vivoinnovationknock-downmutantnoveloverexpressionpreventpromoterstemtherapeutically effectivetranscriptometranscriptome sequencingtumor
中文摘要
项目总结
砷已被确定为皮肤癌、肺癌、膀胱癌和肝癌的主要致病因素。砷
污染影响着世界上数亿人。砷的致癌性与
令人震惊的是,大量的人暴露在病毒中,迫切需要研究和理解其
致癌机制,因此可以启动有效的治疗干预。与大多数其他基因不同,
组蛋白信使RNA(MRNAs)如组蛋白H3.1mRNA不以聚(A)尾结束,
相反,它们的3‘端有一个茎环结构。茎环结合蛋白(SLBP)附着在茎上-
组蛋白3‘-加工所需的环状RNA结构。之前我们发现,
砷暴露下调SLBP水平,使典型的组蛋白H3.1 mRNA获得PolyA
尾巴。H3.1基因的多聚腺苷酸化似乎是致癌的,因为它会导致转录失控,
细胞周期停滞和基因组不稳定,并促进锚定非依赖性细胞生长和肿瘤
在裸鼠体内形成。这些影响可能是由于组蛋白H3.3变异体组装的破坏所致,
因为全基因组组蛋白图谱显示H3.1 mRNA的多腺苷基化损害了H3.3
在转录、细胞特性和异染色质扩散的关键部位组装。H3.3实演
在转录、有效的DNA损伤修复、适当的染色体分离以及
发展。H3.3基因的敲除模拟了H3.3组装的破坏,诱导了细胞转化。
此外,H3.3突变与各种类型的癌症有关,强调了H3.3在癌症中的重要性
致癌。基于这些观察,我们假设H3.3组装的中断导致
组蛋白H3.1多聚腺苷酸化是砷中毒的重要诱因
致癌。为了验证这一假说,我们将确定多聚腺苷酸化的机制
规范性组蛋白H3.1 mRNA破坏Aim 1中变异体H3.3的组装,确定是否存在缺陷
H3.3组装与砷诱导的异常转录、细胞周期停滞以及基因组有关
AIM 2的不稳定性,并确定H3.3组装在砷诱导的细胞中的破坏作用
探讨砷暴露是否扰乱H3.3在AIM 3体内的组装
这些研究的创新之处在于有可能揭示H3.3组装的破坏是一种新的机制
砷诱导的致癌作用。
英文摘要
PROJECT SUMMARY
Arsenic has been identified as a prominent causal agent in skin, lung, bladder, and liver cancers. Arsenic
contamination impacts hundreds of millions of people in the world. The carcinogenicity of arsenic coupled with
an alarmingly large number of people exposed creates an urgency for studying and understanding its
carcinogenic mechanisms so effective therapeutic intervention can be initiated. Unlike most other genes,
canonical histone messenger RNAs (mRNAs) such as histone H3.1 mRNA do not end with a poly(A) tail,
instead they have a stem-loop structure at their 3’ end. Stem-loop binding protein (SLBP) attaches to the stem-
loop RNA structure that is required for 3’-processing of the canonical histone mRNA. Previously we found that
arsenic exposure downregulates SLBP levels, allowing the canonical histone H3.1 mRNA to acquire a poly(A)
tail. Polyadenylation of H3.1 mRNA appeared to be carcinogenic, since it induced transcriptional deregulation,
cell cycle arrest, and genomic instability, and facilitated anchorage-independent cell growth and tumor
formation in nude mice. These effects were likely resulting from disruption of variant histone H3.3 assembly,
because genome-wide histone mapping showed that polyadenylation of H3.1 mRNA compromised the H3.3
assembly at the sites critical for transcription, cell identity, and heterochromatin spreading. H3.3 plays
important roles in transcription, efficient DNA damage repair, proper segregation of chromosomes, and
development. The knockdown of H3.3, which mimics disruption of H3.3 assembly, induced cell transformation.
Furthermore, H3.3 mutants have been linked to various type of cancers, underscoring importance of H3.3 in
carcinogenesis. Based on these observations, we hypothesize that disruption of H3.3 assembly resulting
from polyadenylation of canonical histone H3.1 mRNA is a significant contributor to arsenic-induced
carcinogenesis. To test this hypothesis, we will determine the mechanisms by which polyadenylated
canonical histone H3.1 mRNA disrupts assembly of the variant H3.3 in Aim 1, determine whether defective
H3.3 assembly is responsible for arsenic-induced aberrant transcription, cell cycle arrest as well as genomic
instability in Aim 2, and determine the role for disruption of H3.3 assembly in arsenic-induced cell
transformation and explore whether arsenic exposure disrupts H3.3 assembly in vivo in Aim 3. The significance
and innovation of these studies lie in the potential to reveal disruption of H3.3 assembly as a novel mechanism
of arsenic-induced carcinogenesis.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/bs.apha.2022.08.003
发表时间:
2023
期刊:
Advances in pharmacology (San Diego, Calif.)
影响因子:
--
作者:
[Veerappan A, Stavrou A, Costa M]
通讯作者:
Costa M
Persistent transcriptional changes induced by nickel through epigenetic alterations
-
批准号:10077549
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2020
-
负责人:Max Costa
-
依托单位:
Persistent transcriptional changes induced by nickel through epigenetic alterations
-
批准号:9899647
-
项目类别:
-
资助金额:$45.4万
-
财政年份:2020
-
负责人:Max Costa
-
依托单位:
Persistent transcriptional changes induced by nickel through epigenetic alterations
-
批准号:10515635
-
项目类别:
-
资助金额:$41.39万
-
财政年份:2020
-
负责人:Max Costa
-
依托单位:
Persistent transcriptional changes induced by nickel through epigenetic alterations
-
批准号:10294236
-
项目类别:
-
资助金额:$42.16万
-
财政年份:2020
-
负责人:Max Costa
-
依托单位:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
-
批准号:10470848
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2019
-
负责人:Max Costa
-
依托单位:
Arsenic carcinogenesis and disruption of histone variant H3.3 assembly
-
批准号:10407027
-
项目类别:
-
资助金额:$54.15万
-
财政年份:2019
-
负责人:Max Costa
-
依托单位:
MEG3 deletion drives lung tumorigenesis due to environmental nickel exposure
-
批准号:9852426
-
项目类别:
-
资助金额:$27.75万
-
财政年份:2019
-
负责人:Max Costa
-
依托单位:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
-
批准号:10004646
-
项目类别:
-
资助金额:$41.77万
-
财政年份:2019
-
负责人:Max Costa
-
依托单位:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
-
批准号:10681242
-
项目类别:
-
资助金额:$39.3万
-
财政年份:2019
-
负责人:Max Costa
-
依托单位:
Arsenic and Nickel Carcinogenesis in Human Lung Cells
-
批准号:10245059
-
项目类别:
-
资助金额:$40.1万
-
财政年份:2019
-
负责人:Max Costa
-
依托单位:
MEG3 deletion drives lung tumorigenesis due to environmental nickel exposure
-
批准号:10357729
-
项目类别:
-
资助金额:$56.03万
-
财政年份:2019
-
负责人:Max Costa
-
依托单位:
MEG3 deletion drives lung tumorigenesis due to environmental nickel exposure
-
批准号:10579842
-
项目类别:
-
资助金额:$54.87万
-
财政年份:2019
-
负责人:Max Costa
-
依托单位:
Epigenetic Stress and Chromate Carcinogenesis
-
批准号:10165716
-
项目类别:
-
资助金额:$46.6万
-
财政年份:2018
-
负责人:Max Costa
-
依托单位:
Epigenetic Stress and Chromate Carcinogenesis
-
批准号:10406986
-
项目类别:
-
资助金额:$46.1万
-
财政年份:2018
-
负责人:Max Costa
-
依托单位:
SESN2 and therapeutic effect of Isohapontigenin (ISO)
-
批准号:10265326
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2018
-
负责人:Max Costa
-
依托单位:
SESN2 and therapeutic effect of Isohapontigenin (ISO)
-
批准号:10450132
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2018
-
负责人:Max Costa
-
依托单位:
Epigenetic Stress and Chromate Carcinogenesis
-
批准号:9768470
-
项目类别:
-
资助金额:$49.05万
-
财政年份:2018
-
负责人:Max Costa
-
依托单位:
Arsenic Carcinogenesis and Interference With Histone mRNA
-
批准号:8997324
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2016
-
负责人:Max Costa
-
依托单位:
SATB2 and Nickel Carcingenesis
-
批准号:8685083
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2014
-
负责人:Max Costa
-
依托单位:
SATB2 and Nickel Carcingenesis
-
批准号:8842984
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2014
-
负责人:Max Costa
-
依托单位:
海外基金